Pharmaceutical Sciences
Pharmaceutical Sciences covers research areas of nanomedicine, drug delivery; drug metabolism, pharmacokinetics and toxicology; pharmacogenomics and pharmacogenetics; diabetes, cardiovascular and molecular pharmacology; neuropharmacology; cancer pharmacology; pharmaceutical health outcomes and pharmacotherapeutics; and pharmaceutical education.
Faculty Members
| Name | Research Interests |
|---|---|
| Burt, Helen Mary | Nanotechnology, non-sized drug carriers, nanoparticulte drug delivery |
| Cairns, Brian | Neuropharmacology; Oro-Facial Pain; Pain; Electrophysiology; pain mechanisms; headache; temporomandibular disorders; sex-related differences; peripheral analgesics |
| Chang, Thomas | Drug Metabolism; Pharmacology; Nuclear Receptor; Drug-Metabolizing Enzymes; Cytochrome P450; Gene Expression; Gene regulation |
| Collier, Abby | Drugs in children, Drugs in pregnancy, Developmental pharmacology, Drug metabolism, Pharmacokinetics, Drug metabolism and pharmacokinetics, primarily of the phase II (conjugation) enzymes, focused on pregnancy and pediatrics |
| Conklin, Annalijn | Chronic Diseases in Elderly; Gender Epidemiology; Health Policies; Professional Practices; Obesity; Social Determinants of Dietary and Metabolic Disorders; Community Health / Public Health; healthy ageing; social nutritional epidemiology; obesity & CVD risk factors; food and nutrition policy; Indigenous health; gender and health equity; healthcare quality improvement; disease management evaluation |
| Coughtrie, Michael | Drug metabolizing enzymes |
| Cragg, Jacquelyn | Drug Effectiveness; Drug Safety; Epidemiology; SCI Progression; neuro-analytics; Neurological diseases; Parkinson’s disease; Amyotrophic Lateral Sclerosis (ALS); multiple sclerosis |
| De Vera, Mary | examining how eHealth technologies can support new and existing models of care to improve care delivery and patient outcomes; exploring patients' perspectives and experiences with medication taking and adherence; and evaluating the use and impacts of medications among pregnant women, particularly with inflammatory conditions. |
| Frankel, Adam | Biological and Biochemical Mechanisms; Bioactive Molecules; Organic Molecules and Biomolecules; Proteins; Protein Biochemistry; arginine methylation; post-translational modifications; drug discovery; yeast; autophagy; Chemical Biology |
| Giaever, Guri | Model organisms, human therapeutics, high-throughput cell biology, drug synergy, technologies for understanding relationship between chromatic structure and transcriptional regulation |
| Hafeli, Urs | Pharmacokinetics; Imaging; Radiotherapy; Immunotherapy; Development of Drug Delivery Systems; Radiopharmaceuticals; Radioimmunotherapy; Magnetic Targeting; Targeted Drug Delivery; Novel polymers; Nanoparticles; Microspheres; Microneedles; Bioconjugates |
| Harrison, Mark | measurement and valuation of health, health technology and policy assessment, and preferences for healthcare interventions; evaluation/re-evaluation of the type of health care that is provided, the point in the treatment pathway, and the way in which it is delivered |
| Hedtrich, Sarah | Nanotechnologies; Structural Tissue Engineering / Biomaterials; Inflammatory Respiratory Diseases; Skin; Novel therapies for inflammatory and genetic diseases of human epithelia; Tissue Regeneration and Wound Healing; Topical drug delivery and Nanomedicine; New Biomedical Approaches - Alternatives to Animal Testing |
| Jarvis-Selinger, Sandra Ann | Education, human learning, development, and instruction, education innovation, konwledge translation, teaching excellence, curriculum design, technology |
| Karim, Ehsan | Causal inference, Biostatistics, Epidemiology, Statistical learning, Big-data analytics, Bayesian methodologies |
| Kumar, Ujendra | Somatostatin hormone, molecular pharmacology, Somatostatin, , Hormones, somatostatin, locomotor and cognitive function, neurodegenerative diseases, drugs |
| Lalji, Fawziah | Pharmacoepidemiology; Infectious Diseases; Vaccination; Antibiotics and Resistance; Tuberculosis |
| Li, Shyh-dar | drug delivery; pharmaceutics; nanomedicine; biopharmaceutics |
| Loewen, Peter | Cardiovascular Diseases; Arrhythmia; Thrombosis and Embolism; Heart Failure; Pharmacoepidemiology; Stroke; Health Care Technologies; Professional Practices; Hematology; Decision Making; atrial fibrillation; stroke prevention therapy; adherence to medication; Shared decision-making; pharmacy practice; knowledge translation of evidence to patient care; patient education; clinical prediction rules; prediction of stroke and bleeding in atrial fibrillation patients; patient decision aids; patient complexiometry; healthcare communication technologies; use of mobile technology for clinical decision-making; hospital pharmacy practice; quality of care, quality drug therapy |
| Lynd, Larry | health economics, orphan drugs, pharmaceutical policy, respiratory medicine, epidemiology, pharmacoepidemiology, rare diseases |
| Maharaj, Anil | |
| McCormack, James | Knowledge translation and evidence-based practice |
| Nislow, Corey | genomics and develops biotechnology tools to address both fundamental and applied biological questions; Parallel genome-wide chemical genomic screens; High throughput cell-based screens; Next Generation Sequencing |
| Page, Brent | Cell Signaling and Cancer; drug discovery; Drug development; Medicinal Chemistry; Chemical Biology; Cancer; Target Engagement; Cell signaling |
| Rodrigues, Brian | Diabetes; Cardiomyopathy; Heart Failure; Energy Metabolism; Cardiovascular metabolism; Endothelial cell - cardiomyocyte crosstalk; Vascular Endothelial Growth factors |
| Ross, Colin | Biomedical Technologies; Gene Therapy; Drug Metabolism; Transgenic Model; Pharmacogenomics; Gene-based therapeutics; Precision Medicine |
| Sadatsafavi, Mohsen | Respiratory diseases; Epidemiology (except nutritional and veterinary epidemiology); Epidemiology; Biostatistics; Respiratory Research |
| Soja, Peter | how synaptic transmission through identified ascending spinal sensory pathways and motoneuron pools differs during distinct behavioral states such as non-rapid eye movement (NREM) and REM sleep, or general anesthesia vs. wakefulness |
| Turgeon, Ricky | Cardiology and circulatory sciences (including cardiovascular disease); Health care effectiveness and outcomes; Knowledge translation and implementation science in health; Heart failure pharmacotherapy; Acute coronary syndromes / myocardial infarction; Cardiovascular risk reduction (lipid-lowering therapy, antiplatelet therapy); Cardiovascular safety of medications; Drug Effectiveness; Evidence-based practice; Shared decision making; Point-of-care decision aids / decision support tools; Knowledge translation / implementation; Risk calculators / clinical prediction tools; Pharmacist scope of practice; Clinical assessment / physical examination |
| Wilbur, Kerry | Professional Practices; Education Systems; workplace-based learning; culture and health professional education; patient and medication safety; interprofessional education; public health roles of pharmacists |
| Williams, Karla | Oncology |
| Wong, Judy | Carcinogenesis, cancer, aging, genetics, chromosome stability, cancer biology, pharmacology, pharmacognetics, human genetics, genomes, DNA, genomics |
| Wong, Harvey | applications of translational modeling and simulation techniques to optimize drug dose and regimen for new therapeutics, and to better understand emergence of cancer tumor drug resistance |
| Zed, Peter | Pharmacotherapy, cardiovascular disease, infectious disease, airway pharmacology, sedation and analgesia, evidence-based medicine, adverse drug events, Pharmacotherapy best practice in emergency medicine and patient safety, particularly adverse drug events |
